Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Leaflet IPRATROPIU/SALBUTAMOL TEVA 0.5mg/2.5mg PE 2.5ml 0.5mg / 2.5mg / 2.5ml solution for inhalation by nebuliser
- Product code:
- W56438001
- Quantity:
- 5
- Indicated for:
- nasal congestion; rhinitis
- Route of administration:
- inhalation
- Substance:
- ipratropium bromide + salbutamol (antimuscarinic bronchodilator + beta-2 adrenergic agonist)
- ATC
- R03AK04 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
Precautions:
Anticholinergic effects
May cause dry mouth, constipation, urinary retention, or blurred vision.
Hyperglycemia
This medicine may increase blood sugar.
Elderly warning
Older people may have an increased risk of side effects.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
The combination of ipratropium bromide and salbutamol is used for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma. Ipratropium bromide works by blocking muscarinic receptors, while salbutamol stimulates beta-2 adrenergic receptors, relaxing airway muscles.
The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to achieve the best results.
Side effects may include dry mouth, cough, tremors, or palpitations. In rare cases, severe allergic reactions or breathing difficulties may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.
The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to achieve the best results.
Side effects may include dry mouth, cough, tremors, or palpitations. In rare cases, severe allergic reactions or breathing difficulties may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.
General data about IPRATROPIU/SALBUTAMOL TEVA 0.5mg/2.5mg PE 2.5ml 0.5mg / 2.5mg / 2.5ml
- Substance:
- ipratropium bromide + salbutamol
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W56438001
- Concentration:
- 0.5mg / 2.5mg / 2.5ml
- Pharmaceutical form:
- solution for inhalation by nebuliser
- Quantity:
- 5
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for ipratropium bromide + salbutamol
- 0.5mg/2.5mg
- 0.5mg/2.5mg/2.5ml